ABSTRACT Heart failure bring outs ...

ABSTRACT

Heart failure bring outs secondary to an insult to the cardiovascular body The insult results in cardiac, circulatory, and skeletal muscle alterations. These compensatory alterations may initially be effective in normalizing cardiocirculatory function. However, in time, the changes become restrictive, especially during exertion. Consequently many heart failure patients are many times hospitalized, suffer from functional limitations, and have a high mortality rate. Management of heart failure patients has become increasingly multidisciplinary, and the composition of the team and relative importance of its members must constantly change depending forward the patient's status. This review outlines factors that contribute to exercise tolerance, a marker of clinical severity of the disease. In addition, the character of exercise training for these patients is defined. Evidence indicates that patients with stable heart failure should participate in exercise training. The guidelines for and constituents of exercise training are similar to other clinical populations. However, the exercise prescription should be tailored to each patient's unique demands and goals. As a deduction of training, many of the peripheral abnormalities improve. These improvements translate to increased exercise tolerance, reduc activity-related symptoms, and improved quality of life. Finally, exercise training increases survival time and decreases health care costs

INTRODUCTION

An estimated 5 million Americans have heart failure, a chronic condition associated with of common occurrence hospitalizations, widespread functional limitations, and a high mortality rate. Each year, approximately 550000 of recent origin cases are diagnosed and nearly 300000 patients die of heart failure as a primary or contributory cause.1 somewhat old individuals are particularly at risk for developing heart failure. In fact, heart failure is the principally common hospital discharge diagnosis for patients across 65 years. The syndrome is the underlying reason for 12 to 15 million office visits and 65 million hospital days each year.2 Furthermore, during the last 10 years, the annual number of hospitalizations has increased from approximately 550000 to nearly 900000 for heart failure as a primary and from 17 to 26 million for heart failure as a secondary diagnosis.3

In addition to the substantial morbidity and mortality associated with this condition, there is a significant financial impact in succession our society. In fact, heart failure is now the single greatest in quantity costly cardiovascular illness in the United States, with total yearly treatment expenses estimated at $24.3 billion.1 The sumptuousness to society is expected to increase becoming to an aging population and put offed survival rates of individuals with cardiovascular disease, therefore imposing a large carrying capacity on individuals and the health care system

Heart failure is defined as the pathophysiological state in which abnormal cardiac function is responsible for failure of the heart to cross-examine blood at a rate commensurate with the requirements of the metabolizing tissues, or to do thus only from an elevated filling pressure4 Heart failure is not a homogenous disease. Rather, it is the final general pathway of several disorders that impair the heart's pumping ability. Three distinct etiologies of heart failure include (1) intrinsic myocardial disease secondary to coronary heart disease, cardiomyopathy, and infiltrative disease; (2) exces work load owed to increased resistance to ejection secondary to hypertension and hypertrophie cardiomyopathy or increased misfortune volume (volume load) secondary to aortic insufficiency and valvular insufficiency; and (3) myocardial damage from mix with drugss or radiation therapy.1

Because heart failure is not a homogenous disease, management of the patient is extremely challenging with constant ne for end monitoring and follow-up care. Primary goals of heart failure management include a reduction in the frequent occurrence of heart failure exacerbations, extending life, and improving quality of life. Additional goals include maximizing independence, improving exercise capacity, enhancing emotional well-being, and reducing resource use and outlay of care.6

As a inference of the increasing incidence of heart failure and the manifold nature of the syndrome, the management of patients has become increasingly multidisciplinary in nature. Moreover, the composition of the team and relative importance of its members must constantly change depending upon the status of the patient. The project of this review is two-fold: (1) to discuss factors that contribute to exercise tolerance, a marker of the clinical severity of the disease, and (2) to current general exercise guidelines in this patient population.

FACTORS CONTRIBUTINGTO EXERCISE INTOLERANCE IN CHRONIC HEART FAILURE

The treatment of heart failure is aimed at correcting the underlying cause and/or controlling the heart failure state. The management of the heart failure patient generally includes a combination of pharmacological amalgamates aimed to relieve clinical symptoms and extend life.7 Numerous pharmacological agents are available which help improve central hemodynamics from reducing cardiac afterload or enhancing myocardial contractility. Additional pharmacological agents are used to abridge excessive fluid retention. Following initiation of as it was therapy, mortality is reduced and many patients experience resolution of their symptoms at rest" However, most numerous patients continue to experience activity-related symptoms, including shortness of breath, muscle fatigue, and weakness. As a follow patients with heart failure ofttimes complain of chronic fatigue and are unable to perform many of their normal activities of daily living. Thus, despite traditional pharmacologic treatment, the clinical phase of heart failure includes a marked decline in functional state, as defined by means of exercise tolerance and capacity with a posterior decrease in quality of life.